Akèy › Kansè Poumon ki pa ti selil › Virginia › Roanoke
Etid klinik pou Kansè Poumon ki pa ti selil nan Roanoke, VA
8 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Roanoke (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Ap rekriteFaz 2/3
- Blue Ridge Cancer Center, Blacksburg · 26 mi lwen
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Ap rekriteFaz 3
- Blue Ridge Cancer Care ( Site 0144), Roanoke
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Ap rekriteFaz 3
- Blue Ridge Cancer Care, Christiansburg · 28 mi lwen
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Oncology & Hematology Associates of Southwest Virginia, Inc.,DBA Blue Ridge Cancer Care, Roanoke
- Oncology & Hematology Associates of Southwest Virginia Inc dba Blue Ridge Cancer Care, Salem · 6 mi lwen
- Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care, Blacksburg · 26 mi lwen
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Ap rekriteFaz 3
- Clinical Study Site, Blacksburg · 26 mi lwen
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Ap rekriteFaz 1/2
- Oncology & Hematology Associates of Southwest Virginia, Inc, Blacksburg · 26 mi lwen
MYLUNG Consortium Part 3: Observational Study
Ap rekriteEtid obsèvasyon
- Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg · 26 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Carilion Roanoke Memorial Hospital, Roanoke
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY120 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH56 etid
- Washington, DC55 etid
Lòt etid nan Roanoke
- Kansè kolorektal10 etid
- Ensifizyans kadyak9 etid
- Kansè pwostat7 etid
- Kansè nan tete7 etid
- Kansè Metastatik6 etid
- Pye Dyabetik5 etid
- Kansè ovè4 etid
- Kansè lestomak4 etid
- Melanom4 etid
- Kolit Ulseratif4 etid
- Kansè poumon selil ti4 etid
- Maladi Crohn4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.